The Oral-Cancer Link

The Mouth’s Microbial Ecosystem

The human mouth is teeming with microscopic life. In fact, the oral cavity harbors over 700 species of bacteria, making it the second most diverse microbial community in the body after the gutmdpi.com. (And that’s not counting the viruses, fungi, and protozoa also living there.) This rich microbiome thrives thanks to the mouth’s hospitable conditions: a warm ~37 °C temperature, constant moisture, and a neutral-ish pH around 6.5–7.0 provide ideal growth conditionsmdpi.com. From the hard enamel surfaces of teeth to the soft tissues of the gums, cheeks, and tongue, distinct microbial communities colonize every nookmdpi.com.

Crucially, these microbes are not merely passive squatters – many are symbiotic partners that help keep us healthy. In a balanced state, the oral microbiome contributes to normal physiology: for example, “good” bacteria can aid in digestion and nutrient metabolism and even help regulate blood pressure by producing nitric oxide from dietary nitrates. Harmless commensal microbes also compete with or inhibit disease-causing bugs, effectively acting as bodyguards in our mouths. In essence, a diverse and balanced oral microbiome supports both oral and systemic healthmdpi.com. Each person carries a core oral microbiome – a set of microbial species common to most people – plus a variable component unique to the individual’s diet, habits, and environmentmdpi.com.

But this harmonious ecosystem can be disrupted. Factors like high sugar intake, smoking, alcohol use, certain medications, or diseases (like diabetes) can perturb the oral environment (for instance by lowering salivary pH or reducing saliva flow). These changes tip the ecological balance, allowing normally minor players to overgrow – a state of dysbiosis. When dysbiosis sets in, microbes that once peacefully coexisted may turn against us: some start producing excess acids or toxins, and the immune system is provoked into chronic inflammation. The result is often oral disease (tooth decay or gum infections) and, as scientists are increasingly realizing, potentially problems well beyond the mouthdentalcare.commdpi.com.

From Plaque to Problems: How Oral Biofilms Form

Understanding oral health (and disease) begins with dental plaque – the films of bacteria on our teeth. Plaque is not just leftover food debris; it’s a living biofilm “city” constructed by microbes. Its formation begins within minutes after we clean our teeth: saliva proteins rapidly coat the tooth surface, forming an acquired pellicle that bacteria can stick tomdpi.commdpi.com. Pioneer colonizers – largely gram-positive streptococci (e.g. Streptococcus mutans and its cousins) – are the first to attach. They multiply and secrete sticky polymers, building a slimy matrix that anchors them to the pellicle and to each other. Soon, other bacteria join in. A remarkable succession unfolds as the biofilm matures: early aerobic microbes create an oxygen-poor microenvironment that invites anaerobic species to thrive beneath. A keystone in this assembly is Fusobacterium nucleatum, a long rod-shaped anaerobe that binds to virtually all other oral bacteria. F. nucleatum acts as a molecular Velcro between early and late colonizers – it can adhere to the initial streptococci as well as to later-arriving pathogens that wouldn’t otherwise stick to the toothnature.com. In this way, F. nucleatum and other “bridging” species help the plaque community expand into a complex, multi-layered structure.

Over hours to days, the plaque biofilm develops a highly organized architecture. Bacterial cells cluster into microcolonies encased in a self-produced extracellular matrix (a mix of sugary polymers, proteins, and DNA). The matrix is not solid; it’s laced with fluid-filled channels that allow circulation of nutrients and waste, rather like plumbing in a high-risedentalcare.com. The biofilm’s architecture creates microenvironments – pockets of differing pH, oxygen, and nutrient levels – that different microbes exploit. The community even communicates: bacteria within plaque secrete chemical signals to sense their neighbors and coordinate behavior through quorum sensingdentalcare.com. Triggered by these signals, plaque bacteria can collectively upregulate virulence genes (for example, to produce acids or enzymes when the biofilm is under threat) and even sacrifice certain members for the greater good of the community. In essence, mature dental plaque behaves less like a random smear of germs and more like a unified, purpose-built organism.

Unfortunately for us, a mature biofilm is stubborn. The same matrix that shelters the plaque community also blocks outside attacks. Antimicrobial agents (like mouthwash) and even our immune system struggle to penetrate. Bacteria living in plaque can resist antibiotics at concentrations up to 1,000× higher than what would kill free-floating (“planktonic”) bacteriadentalcare.com. This helps explain why simply rinsing with antiseptic has limited effect once a thick plaque has formed – and why dentists harp on mechanical removal (brushing and flossing) to disrupt biofilms. Left undisturbed, plaque can mineralize into tartar and continue to thicken, providing a fortress for pathogenic bacteria. Over time, the balanced microbial community shifts toward a disease-causing one.

Two common outcomes of plaque overgrowth are dental caries and periodontal disease. In cavities, acid-producing bacteria like Streptococcus mutans dominate; they ferment sugars to acids, relentlessly eroding tooth enamel and dentinmdpi.com. In gum disease (gingivitis and periodontitis), a cohort of anaerobic bacteria proliferates in the plaque along the gum line. Notorious members include Porphyromonas gingivalis, Tannerella forsythia, and Treponema denticola (together dubbed the “red complex”), which thrive in oxygen-deprived pockets that form as gums become inflamed and pull away from teeth. Fusobacterium nucleatum is also abundant in periodontal plaques, where its bridging ability knits together communities of early and late invadersnature.com. These bacteria release toxins and foul-smelling metabolites, provoke chronic inflammation that erodes the supporting bone around teeth, and can directly invade gum tissue. If plaque is the city, periodontal pathogens are its crime bosses – driving the destruction of gum architecture and leading ultimately to tooth loss.

It’s clear that oral biofilms, when unbalanced, cause local disease. But their influence may not stop at the gum line. As we’ll see, microbes from dental plaque can escape into the wider body, with surprising consequences.

Oral Health and Whole-Body Health

For centuries, folk wisdom and physicians alike have suspected links between oral health and general health. Only in recent decades have scientists begun to map out these connections. Chronic gum disease (periodontitis), for example, has been epidemiologically associated with a higher risk of a number of seemingly unrelated conditions: cardiovascular disease, stroke, diabetes, rheumatoid arthritis, adverse pregnancy outcomes, and even neurodegenerative diseasesmdpi.com. The nature of these links is complex. Poor oral health often coexists with other risk factors (smokers or those with poor diets may be prone to both dental and systemic problems, for instance). This makes cause and effect hard to disentangle – does gum disease cause heart disease, or are they both the result of an inflammatory-prone individual with certain lifestyle habits? In many cases, the relationship is likely bidirectional and multifactorial.

Still, some connections are clearly more than coincidence. Oral bacteria frequently enter the bloodstream through ulcerated gum tissues – a phenomenon known as transient bacteremia. Even routine activities like chewing or vigorous brushing can introduce oral microbes into circulation. In people with heart valve defects, oral streptococci that hitchhike from the mouth can infect the heart lining (endocarditis). Oral bacteria have been found within atherosclerotic plaques in arteries, suggesting they might contribute to inflammation in situnature.com. One theory is that chronic periodontal infection “primes” the immune system and exacerbates systemic inflammation – a key driver in ailments like atherosclerosis and diabetes. Supporting this, markers of inflammation (like C-reactive protein) are often elevated in those with severe gum disease, and treating periodontitis can sometimes improve blood sugar control in diabetics.

Notably, Fusobacterium nucleatum – our plaque bridging bacterium – has turned up in a variety of unexpected places in the body. It’s been implicated in infections of the head and neck, in certain pregnancy complications (like stillbirth and preterm labor when oral Fusobacterium somehow colonize the uterus), and even in remote abscessesnature.com. This wide dispersal hints that oral microbes, under the right conditions, can travel and colonize far beyond the mouth. Perhaps the most startling discovery in recent years has been the recurring presence of F. nucleatum in colorectal tumors. Researchers have found DNA and live colonies of this oral anaerobe in colon cancer tissue, linking the state of one’s gums with the development of cancer in the gutnature.comnature.com. It’s a connection few would have imagined – the “tooth plaque to tumor” route – and it is now shining a new light on how deeply oral health intertwines with overall health. To understand this odd association, we need to follow F. nucleatum on its journey from mouth to colon.

A Curious Connection: Mouth Bacteria in Colorectal Cancer

Colorectal cancer (CRC) is one of the world’s most common malignancies, and for decades diet, genetics, and environment have been the main known factors. In the past ten years, however, scientists have uncovered a surprising microbial pattern: colorectal tumors are often overgrown with the DNA (and live cells) of oral bacteria, especially Fusobacterium nucleatum. In 2012, sequencing studies first reported that Fusobacterium species were markedly enriched in colorectal tumor tissue compared to normal colon tissuenature.com. Soon, multiple studies around the world confirmed this findingnature.com. F. nucleatum – rarely found in healthy intestines – consistently shows up in a significant subset of colon cancers and in higher quantities than in adjacent normal gut tissuenature.com. Moreover, patients whose tumors harbor high levels of Fusobacterium tend to have worse outcomes: higher risk of recurrence, more frequent metastases, and shorter survival on averagenature.com. This pattern immediately raised a profound question: could the bacteria be causing the cancer to grow, or were they just opportunists living in tumors already formed?

It’s not unusual for microbes to gravitate to tumors – cancer tissue can provide a nutrient-rich, immune-privileged niche. So, initial skepticism was warranted. Was F. nucleatum merely a passenger, thriving in cancers initiated by other forces? Or could it be an active driver, promoting tumor growth and spread? Researchers noted that Fusobacterium didn’t uniformly appear in all colon cancers, hinting that specific strains might be responsible. In fact, experiments in mice and lab cultures had been inconsistent – some F. nucleatum isolates seemed to accelerate cancer, while others had little effectnature.com. This suggested that only certain Fusobacterium lineages might be truly cancer-causing (oncogenic), while others were benign. The hunt was on for the true culprits at the strain level.

Zooming In: A Cancer-Causing Clade of Fusobacterium

In 2024, a breakthrough study in Nature finally pinpointed the suspect. Melissa Zepeda-Rivera and colleagues performed an in-depth genomic analysis of F. nucleatum strains from colorectal cancer patientsnature.com. They cultured 55 Fusobacterium strains from tumor samples of 51 CRC patients and compared them to 80 Fusobacterium strains isolated from the oral cavities of healthy individualsnature.com. By sequencing and comparing all these genomes, the researchers discovered a telltale difference: nearly all the tumor-derived strains belonged to a particular branch of F. nucleatum, which turned out to be a previously unrecognized clade of the speciesnature.com.

F. nucleatum has several subspecies; one common oral subspecies is called F. nucleatum animalis. Within F. n. animalis, the team found two genetically distinct clades, which they labeled Fna Clade 1 (C1) and Clade 2 (C2)nature.com. These two clades are closely related (around 91–93% identical at the genome level) but not identical. Strikingly, only Clade 2 was abundant in tumorsnature.com. In patients’ cancer tissue, Fusobacterium was almost exclusively of the C2 type, whereas the C1 type, despite being common in the mouth, was largely absent from tumors. In other words, the association of F. nucleatum with colorectal cancer was being driven by this specific lineage, Fna Clade 2nature.comnature.com. Clade 1 strains, by contrast, seemed to remain harmless denizens of the oral cavity.

What makes Clade 2 so special? The study identified 195 genetic features enriched in Clade 2 strains that likely equip them for life (and mischief) in the colonnature.com. Many of these genes hint at an enhanced ability to survive the journey from mouth to gut and then thrive in the colorectal environment. For example, every C2 strain possessed a glutamate-dependent acid resistance (GDAR) system – one of the most potent acid survival mechanisms known in gut bacteria – which was completely absent in Clade 1nature.com. This system allows bacteria to endure extreme acidity by pumping out protons in exchange for glutamate, which is converted to protective GABA. Lab tests showed that C2 bacteria survived for at least an hour in a simulated gastric acid environment (pH 3) when glutamate was present, whereas C1 bacteria (lacking the GDAR genes) were rapidly killednature.com. In essence, Clade 2 strains wear an acid-proof vest, making them far more likely to make it through the stomach alive to reach the colon.

Clade 2 also carries genetic tools to feast on nutrients that are bountiful in the gut but scarce in the mouth. Notably, C2 genomes harbored complete operons for metabolizing ethanolamine and 1,2-propanediol – chemical byproducts of digestion found in the intestinal lumennature.com. These operons made up a whopping 20% of Clade 2’s unique gene contentnature.com. Why would this matter? Ethanolamine (from cell membrane breakdown) and 1,2-propanediol (from fermentation of sugars) are plentiful resources in the colon. Gut pathogens that can consume these compounds gain a growth advantage and also sense when they’re in the intestine (these metabolic pathways often double as environmental sensors regulating virulence)nature.com. Clade 1 strains, adapted to the oral niche, lack these operons – they simply can’t eat what’s on the menu in the colon. Clade 2, in contrast, arrives equipped with a full dining set for the gut buffet, giving it a competitive edge once it gets there.

Beyond metabolism, Clade 2 packs a more formidable virulence arsenal. The Nature study found that several known Fusobacterium virulence genes – especially those encoding certain adhesins (surface proteins that mediate sticking to hosts or other bacteria) – differed between C1 and C2nature.com. Paradoxically, some adhesins used for oral colonization (like RadD and FadA2, which help Fusobacterium latch onto other oral bacteria and epithelial cells) were actually enriched in Clade 1 and less common in Clade 2nature.com. But Clade 2 made up for it by possessing others: for instance, the gene for Fap2, an adhesin/autotransporter protein, was entirely absent in C1 yet universally present in C2nature.com. Fap2 is a multi-function virulence factor known to bind host cell receptors (including a sugar on colorectal cells and an immune cell checkpoint receptor)nature.com. Its presence in C2 – along with a toxin gene called fusolisin – suggested that C2 strains might be better at adhering to and invading colon tissue and at evading immune attacknature.com. Indeed, when researchers co-incubated bacteria with human colon cancer cell cultures, Clade 2 strains invaded the cells at significantly higher rates than Clade 1 strainsnature.com. Under the microscope, far more C2 bacteria were seen penetrating into the cancer cells, corroborating that C2 is inherently more aggressive in interacting with host tissue.

Interestingly, the two clades even look different. Under the microscope, Clade 2 cells are on average much longer and slimmer than Clade 1 cells (about 5.3 µm long × 0.33 µm wide for C2, versus 2.0 µm × 0.39 µm for C1)nature.com. Bacterial cell shape can affect how they move, colonize surfaces, and resist phagocytosis by immune cellsnature.com. The elongated form of C2 might help it snake deeper into mucus layers or even tissue crevices in the colon, or possibly avoid being engulfed easily by immune cells – though these hypotheses remain to be tested.

All these attributes paint a picture of Fna Clade 2 as a strain supremely adapted to transit from the mouth to the gut and establish a foothold in the colorectal nichenature.com. It can survive stomach acid, utilize gut-specific nutrients, strongly adhere to colon cells, and potentially perturb the local immune response. Little wonder, then, that this clade thrives specifically in colorectal tumors. Supporting this, the researchers checked additional human datasets and found that only Clade 2 shows up in cancerous tissue. In 116 colorectal cancer patients, F. nucleatum Clade 2 was significantly enriched in tumors compared to normal adjacent tissue, whereas Clade 1 was notnature.com. And when they analyzed stool samples from nearly 1,250 people (about half with CRC, half healthy), Fusobacterium DNA was detected in 29% of cancer patients vs only 5% of healthy controlsnature.com. Crucially, both clades could sometimes be found in stool, but only Clade 2 was significantly more prevalent in the cancer patients’ microbiomesnature.com. In other words, Clade 1 might transiently pass through intestines on occasion, but Clade 2 is the one that really takes hold in people with colorectal tumors. These findings pinpoint Fna Clade 2 as the true oral bacterium linked to colorectal cancer – the “smoking gun” strain connecting an unhealthy mouth to malignant growth in the colonnature.com.

Proving Causation: Bacteria That Drive Tumors

Discovering which bacteria associate with tumors is one thing – proving they contribute to cancer development is another. To nail down causation, Zepeda-Rivera et al. went beyond correlation and directly tested Clade 2’s cancer-promoting ability in the lab. First, they infected a culture of human colon cancer cells with either a mix of Clade 2 bacteria or Clade 1 bacteria. The result: Clade 2 bacteria invaded the cancer cells at a higher rate, as mentioned, and also induced more pro-inflammatory and pro-growth changes in the cells (observations consistent with prior reports of Fusobacterium spurring cancer cell proliferation)nature.com. This hinted that C2 is functionally more virulent toward colon cells than C1, but the ultimate test came in live animals.

The researchers turned to a mouse model that is genetically prone to develop intestinal tumors (mimicking human colon cancer initiation). They gavaged groups of these mice with either Clade 2 bacteria, Clade 1 bacteria, or a placebo, and then monitored tumor formation in the gut. The differences were stark. Mice that regularly received oral doses of Clade 2 developed significantly more and larger tumors (benign polyps and adenomas) in their intestines compared to mice given Clade 1 or no bacterianature.com. In contrast, Clade 1-treated mice showed tumor loads similar to the control groupnature.com. This experiment provided direct evidence that F. nucleatum Clade 2 can drive tumorigenesis in a susceptible host, whereas Clade 1 cannot. It’s a smoking gun: the bacteria didn’t just show up after the fact – they actively contributed to tumor growth.

Equally interesting were clues how Clade 2 might be promoting cancer. When the team analyzed the mouse tissues, they found signs that C2 infection “reprogrammed” the gut environment in an oncogenic direction. Metabolic profiling indicated alterations in glutathione metabolism – hinting that the bacteria might be depleting this important antioxidant in the gut mucosanature.com. Glutathione depletion would lead to a buildup of oxidative stress (DNA-damaging free radicals), which can accelerate the accumulation of mutations in cells. Indeed, markers of oxidative stress and inflammation were elevated in the C2-exposed micenature.com. The pattern suggests that Fusobacterium C2 creates a chronically inflamed, pro-oxidant milieu in the colon that is fertile ground for tumors to form or progress. Interestingly, the total number of tumors induced by C2 was modest – Clade 2 seemed to act more as a tumor fertilizer than a seed, worsening and enlarging nascent tumors more than sparking entirely new onesnature.com. This dovetails with clinical observations: Fusobacterium is often associated with more aggressive, advanced cancers (and especially with cancer spread)nature.comnature.com, suggesting it may have a bigger role in tumor progression rather than initiation.

By this point, the picture is compelling: A strain of mouth bacteria travels to the colon, finds a niche in developing tumors, and actively makes those tumors grow faster and behave more aggressively. But mechanistically, how exactly might bacteria boost cancer? The field is still uncovering answers, but several plausible mechanisms have emerged:

• Genotoxicity and DNA damage: Certain bacteria produce toxins that directly damage DNA in host cells. A prime example is Escherichia coli carrying the colibactin gene cluster, which can cause mutations that leave a “signature” in colorectal cancer DNAnature.com. While F. nucleatum doesn’t have a known classic genotoxin, the oxidative stress it triggers can lead to DNA damage in colon cells over time. Chronic infection = chronic injury to DNA = higher chance of cancerous mutations.

• Chronic inflammation: Many bacteria incite persistent inflammation, which bathes nearby cells in a slew of immune mediators. These include reactive oxygen and nitrogen species (which can mutate DNA) and growth factors that encourage cells to proliferate and resist death. Fusobacterium is known to activate inflammatory pathways (e.g. via toll-like receptors on immune cells). In the tumor context, F. nucleatum likely recruits tumor-infiltrating immune cells and skews them toward a pro-tumor phenotype (for example, tumor-associated macrophages that actually help tumors grow). The study’s findings of upregulated inflammatory pathways in C2-colonized mice support this ideanature.com.

• Cellular signaling and proliferation: F. nucleatum can communicate directly with host cells to turn on oncogenic signals. One of its adhesin proteins, FadA, binds to cadherin proteins on colon epithelial cells and activates β-catenin signaling – a key pathway that drives cell proliferation in cancersnature.com. Researchers have shown that Fusobacterium can thus push colon cells to grow and divide more, tipping them toward malignancy. In essence, the bacterium’s presence can hijack the cell’s regulatory circuits, much like pressing a gas pedal for growth.

• Immune evasion and tumor immunity: Normally, emerging cancer cells can be recognized and eliminated by the immune system. F. nucleatum, however, appears to interfere with this immune surveillance. Its Fap2 protein, for instance, can bind to a receptor (TIGIT) on natural killer cells and lymphocytes, blocking their ability to kill cancer cells. Additionally, Fusobacterium’s tendency to induce myeloid-derived immune cells may create an immunosuppressive tumor microenvironment. The net effect is that the immune system becomes less effective at attacking the tumor, allowing cancer cells to flourish unchecked. In line with this, experiments have found that F. nucleatum can cause apoptosis (cell death) of tumor-infiltrating lymphocytesnature.com, essentially disarming the very T-cells and NK cells that are meant to keep cancer in check.

• Microbiome community effects: Tumors with Fusobacterium often have other microbes too, forming a local microbiome. F. nucleatum might act as a pioneer that enables additional bacteria to join, creating a polymicrobial biofilm on the tumor surfacenature.com. These consortia could collectively enhance inflammation or even protect each other from antibiotics and the immune system. (Indeed, F. nucleatum is a known “bridger” – just as it glues together oral biofilms, it may recruit other oral bacteria to colonize the tumor.) The combined metabolic activity of a tumor microbiome might further sculpt the environment – for instance, consuming nutrients or producing metabolites that favor tumor growth.

In summary, there are multiple, non-mutually exclusive ways an oral bacterium like F. nucleatum could tilt the scales toward cancer. Chronically inflamed gums seeding Fusobacterium to the colon might be like planting weeds in a garden – once there, the weed releases chemicals that alter the soil, choke out healthy plants, and attract more pests, until eventually a tumor “jungle” takes over.

Implications and Prevention: The Mouth-Gut Axis

The discovery of an oral bacterium contributing to colorectal cancer is reshaping how we think about cancer prevention and therapy. It suggests a provocative concept: the mouth is part of the pathogenesis of disease in far-flung organs. If a common gum microbe can help drive colon cancer, what about other oral microbes and other diseases? This opens new avenues of research – and in the meantime, underscores old advice about oral hygiene with a new twist.

One immediate implication is in screening and diagnostics. If F. nucleatum Clade 2 is a hallmark of colorectal tumors, could we detect it early to flag at-risk patients? Unlike some elusive cancers, colorectal cancer does shed clues into stool. In fact, the presence of Fusobacterium in stool (especially the specific Clade 2 type) has been proposed as a biomarker that could augment current screening testsnature.com. A stool DNA test that picks up F. nucleatum along with other tumor signals might improve early detection of colon cancer, or identify patients who need a colonoscopy sooner. Ongoing studies are examining how the gut microbiome profile, including oral invaders like Fusobacterium, could be integrated into non-invasive cancer screening.

Another implication is therapeutic targeting. If a microbe is helping a tumor grow, killing that microbe could slow the cancer. Researchers are now experimenting with antibiotics and other means to eradicate F. nucleatum in CRC patients. One small study found that treating mice (and patient tumor samples) with the antibiotic metronidazole, which Fusobacterium is sensitive to, reduced tumor growth and Fusobacterium loadnature.com. Of course, broad antibiotics come with risks and can disrupt the whole microbiome, so precision is key. Scientists are therefore interested in developing phage therapies (viruses that specifically infect Fusobacterium), or small molecules that block Fusobacterium’s critical virulence functions (like its adhesins or metabolic pathways). Another creative idea is using F. nucleatum’s penchant for homing to tumors to our advantage: for instance, engineering bacteria to deliver cancer drugs specifically to the tumor site. While such approaches are in their infancy, the principle of manipulating the tumor microbiome is now on the tablenature.com.

Perhaps the most important lesson of all is preventive: maintaining good oral health might protect more than just your teeth. We’ve long known that brushing, flossing, and regular dental care can prevent cavities and gum disease. Now, it appears they might also reduce the risk of some systemic diseases, potentially including colorectal cancer. A mouth that is clean and balanced is less likely to be a reservoir of aggressive pathogens like Clade 2 Fusobacterium. Conversely, severe periodontal disease could be akin to having an open door for oral bacteria to infiltrate the bloodstream or gut. Epidemiological studies have already hinted at this: poor oral hygiene and chronic periodontitis have been linked to higher overall mortality ratesnature.com, even when controlling for other factors. While correlation isn’t causation, improving oral health is a low-risk intervention with multi-fold benefits. The advice is not new, but it carries extra weight: brush and floss daily, get professional cleanings, treat dental infections promptly, and avoid habits that harm your oral microbiome (excess sugar, smoking, etc.). By doing so, you’re not only preventing tooth decay and gum trouble – you just might be lowering your odds of serious illnesses down the linemdpi.comnature.com.

These revelations are also fostering a more integrated view of medicine and dentistry. Traditionally, oral health has been somewhat siloed from general medical care. But if microbes are the common thread linking oral and systemic diseases, dentists and physicians must collaborate more closely. For instance, gastroenterologists may soon consider evaluating a CRC patient’s gum health or oral microbiome as part of their work-up, and periodontists might flag patients with advanced gum disease for closer screening of other inflammation-related conditions. The concept of a “mouth-gut axis” is emerging, analogous to the well-known gut-brain axis. It means what happens in your mouth doesn’t stay in your mouth – oral bacteria are part of the body’s ecosystem and can influence distant organs.

The story of Fusobacterium nucleatum and colorectal cancer is a vivid reminder that we humans are superorganisms, our fates intimately intertwined with our microbial guests. It took a perfect storm of modern science – high-throughput DNA sequencing, advanced bioinformatics, sophisticated mouse models – to unravel this mouth-to-colon cancer connection. Yet it leads to a rather old-fashioned conclusion: taking care of your oral hygiene and microbial “tenants” is an investment in your overall health. In the future, we may see probiotic mouthwashes, targeted antimicrobial therapies, or even vaccines to keep specific bad actors at bay. But until then, the best approach is simple: keep your friends close and your oral bacteria in balance. Your body – and perhaps your family, who share bacteria through kissing and close contact – will thank you. After all, a healthy mouth isn’t just about fresh breath and a bright smile; it might help keep the rest of you healthy, too, by closing the door to the likes of F. nucleatum Clade 2 and its cancer-promoting kin.

References:

1. Zepeda-Rivera M, et al. Nature. 2024; 628:424–432. PMID: 37228899 nature.comnature.com

2. Kostic AD, et al. Genome Res. 2012; 22:292–298. PMID: 22009990 nature.com

3. Han YW, et al. Cell Host Microbe. 2013; 14(2):195–206. PMID: 23954158 nature.com

4. Gur C, et al. Immunity. 2015; 42(2):344–355. PMID: 25680274 nature.com

5. Komiya Y, et al. Clin Transl Gastroenterol. 2019; 10(7):e00056. PMID: 31343376 nature.com

6. McCoy AN, et al. PLoS One. 2013; 8(4):e53692. PMID: 23577132 nature.com

7. Castellarin M, et al. Genome Res. 2012; 22:292–298. PMID: 22009989 nature.com

8. Rubinstein MR, et al. EMBO Rep. 2013; 14(4):329–337. PMID: 23434853 nature.com

9. Szafranski SP, et al. Trends Cancer. 2022; 8(11):974–984. PMID: 36087828 nature.com

10. Kotronia E, et al. Sci Rep. 2021; 11:16452. PMID: 34376743 nature.comnature.com